← All trials
NCT06481306
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 17, 2024
- Primary completion
- Jan 6, 2027
- Completion date
- Nov 16, 2027
- First posted
- Jul 1, 2024
- Last posted
- Jul 25, 2024
- Enrollment
- 184
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Bristol-Myers SquibbLead sponsor
- Bristol-Myers SquibbOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.